Lanzit Capsules is primarily indicated in conditions like Acid-related dyspepsia, Benign gastric ulcer, Duodenal ulcer, Duodenal ulcer associated with h. Pylori, Esophagitis, Gastric ulcer, Gastro-oesophageal reflux disease, Heart burn, Helico-bacter pylori positive duodenal ulcer, NSAID-associated gastric and duodenal ulcers, NSAID-associated gastric and duodenal ulcers (prophylaxis), NSAID-associated gastric or duodenal ulcers, Peptic ulcer, Resistant ulcers, Zollinger-ellison syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Gl bleeding.
Lanzit Capsules is contraindicated in conditions like Liver diseases.
The severe or irreversible adverse effects of Lanzit Capsules, which give rise to further complications include Epidermal necrolysis, Atrophic gastritis. The symptomatic adverse reactions produced by Lanzit Capsules are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Diarrhea, Constipation, Rashes, Pruritus.
Lanzit Capsules should be used with caution in patients with any pre-existing liver disease or in case of any allergy. It should be used only if clearly needed during pregnancy or lactation. Since gastric acid secretion and other phsiological functions are decreased in elderly patients Lanzit Capsules should be administered with caution.